Sleep Apnea Devices Market (2026 - 2033)

Sleep Apnea Devices Market Summary

The global sleep apnea devices market size was valued at USD 5.1 billion in 2025 and is projected to grow from USD 5.4 billion in 2026 to USD 8.4 billion by 2033, at a CAGR of 6.6% from 2026 to 2033. The market in North America dominated with a revenue share of 47.6% in 2025. As of October 2023, National Council on Aging data indicates that Obstructive Sleep Apnea (OSA), characterized by irregular breathing and reduced oxygen supply to the brain, affects about 39 million adults in the U.S. and an estimated 936 million adults globally.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By product type: Therapeutic devices segment held the largest market share of 78.6% in 2025.
• By end use: Home care segment held the largest market share in 2025.

Regional Highlights

• Largest regional market: North America (47.6% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
• By country: The U.S. held the largest market share in 2025

Market Size & Forecast

• Market size in 2025: USD 5.1 Billion
• Estimated market size in 2026: USD 5.4 Billion
• Projected market size by 2033: USD 8.4 Billion
• CAGR (2026-2033): 6.6%

Three ways to get this report

Buy it, customize it, or ask a question.

Ask an Analyst

Analyst response in 1 business day

• AccessReport author, directly
• Reply timeWithin 1 working day
• No sales callDirect answer only
• FormatEmail reply
• CostFree, no cost

Ask an Analyst

Get the Full Report

What the study covers

• FormatsPDF · Excel · Dashboard
• Timeline2026–2033 annual, 2025 base
• Coverage20+ countries, 5 regions
• Companies10+ key players profiled

Download Free Sample

Customize the Report

20% free customization

• IncludeCountries, segments, points
• TailorTo your product definition
• ExtendDeeper competitor detail
• OrA fully bespoke study
• Turnaround5–10 working days

Tell Us What You Need

ISO 9001 & 27001 certified ESOMAR member Not sure which fits? Call +1-415-349-0058

The high prevalence of sleep apnea in an elderly population often goes undiagnosed due to factors like lack of awareness and non-specific symptoms. With the global population aged 60 and above projected to reach 2 billion by 2050 and the elderly population expected to double from 12% to 22%, the incidence of sleep disorders, particularly OSA, is on the rise. OSA affects 13% to 32% of individuals aged 65 and above. The growing geriatric population's vulnerability to sleep apnea is expected to drive the adoption of sleep apnea devices. Notably, as reported by the U.S. Securities and Exchange Commission, over 8 million CPAP interfaces are sold annually in the U.S., with an additional 2.5 million sold globally.

To learn more about this report, Download Free Sample Report

Market expansion is driven by the entry of new players and an increased focus on innovative product development, resulting in technologically advanced solutions. For instance, the FDA-approved Inspire implant stands out as a unique OSA therapy, addressing the root cause of sleep apnea internally, ensuring regular breathing, and promoting sound sleep.

Market Dynamics

The increasing global burden of obstructive sleep apnea (OSA) remains the strongest growth driver for the sleep apnea devices market. OSA is increasingly associated with obesity, diabetes, cardiovascular diseases, aging populations, and sedentary lifestyles, resulting in a larger patient pool requiring diagnosis and long-term therapy. According to ResMed Inc. August 2025 article, the number of adults in the U.S. diagnosed with obstructive sleep apnea (OSA) is projected to increase to nearly 77 million by 2050, reflecting a 35% rise from 2020 levels. The condition is expected to affect approximately 46% of adults aged 30 - 69 years, driven by demographic shifts and increasing obesity rates. These projections were developed using an open-cohort dynamic population model that accounts for changes in age, sex, and BMI, highlighting the growing demand for sleep apnea diagnosis and treatment solutions. Moreover, growing awareness campaigns and improved screening programs are further increasing diagnosis rates.

Market Concentration & Characteristics

The sleep apnea devices market is currently in a moderate growth stage, with an accelerating pace. This is driven by factors such as a growing geriatric population, a significant patient pool with sleep apnea, an increased prevalence of comorbidities linked to sleep apnea, and the development of advanced devices. For example, NovaResp Technologies Inc. is developing an AI-enabled CPAP algorithm compatible with various CPAP devices, predicting apnea events during sleep.

Market players are utilizing key strategies, including new product launches, expansions, acquisitions, partnerships, etc. For instance, in September 2023, ResMed announced a strategic partnership with Nyxoah to enhance awareness of obstructive sleep apnea and increase therapy penetration in Germany, contributing to market growth in the forecast period.

To learn more about this report, Download Free Sample Report

Degree of Innovation: The sleep apnea devices market has witnessed advancements focused on improving patient comfort, compliance, efficacy, and overall treatment outcomes. Integration of smart technology and digital sensors to enhance therapy management is a key driving factor in the market,

Level of M&A Activities: Mergers and acquisitions in the Sleep Apnea Devices Market are on the rise. Companies are leveraging multiple acquisitions to strengthen product offerings, expand their global footprint, diversify portfolios, integrate technologies, and enhance industry positioning.

Regional Expansion: The global prevalence of sleep apnea presents opportunities and competition across regions. Growing markets in the United Kingdom (UK), Germany, France, Italy, and Spain are driven by aging populations, lifestyle factors, healthcare reforms, and regulatory harmonization. Meanwhile, the well-established U.S. and Canada markets are characterized by high prevalence rates of sleep apnea and advanced healthcare systems.

Analyst Perspective

Positive Airway Pressure (PAP) devices continue to dominate revenue generation, growth is increasingly driven by AI-enabled therapy optimization, cloud-connected platforms, home sleep testing, and minimally invasive alternatives such as hypoglossal nerve stimulation. Rising awareness of sleep disorders, expanding obesity prevalence, and increasing diagnosis rates are creating substantial long-term demand. Companies that integrate intelligent diagnostics, connected therapeutics, and data-driven patient engagement with strong reimbursement support will be best positioned to capture future market growth.

Product Type Insights

Based on product type, therapeutic devices segment dominated the market with the largest revenue share of 78.6% in 2025. This category includes Positive Airway Pressure devices, nasal devices, oral devices, and chin straps. Market players are introducing innovations such as comfortable and lightweight masks, softer materials, smaller masks, and noise-reduction features. Advanced technologies are being integrated to enhance PAP device efficiency and deliver optimal clinical outcomes. The growing patient compliance rate, supported by favorable insurance coverage tied to adherence standards for PAP therapy, is driving widespread adoption, with studies indicating that 80% of diagnosed obstructive sleep apnea patients opt for PAP devices.

Sleep apnea masks segment is anticipated to grow at the fastest rate of 7.9% driven by the widespread adoption of these masks, increasing prevalence of comorbidities related to OSA, and higher adoption of CPAP machines in disease management. Key players are actively looking to innovate product strategies to meet the rising demand. For instance, in October 2023, Fisher & Paykel Healthcare Corporation Limited launched the F&P Solo mask in New Zealand and Australia for obstructive sleep apnea (OSA) treatment. This AutoFit nasal and pillow mask simplifies the setup process, enhancing user convenience. Such initiatives are expected to fuel the segment's growth.

End Use Insights

Based on end use, the home care segment led the market with the largest revenue share in 2025. Technological innovations have resulted in the creation of more portable, user-friendly, and quieter sleep apnea devices suitable for home use. Compact CPAP, BiPAP, and APAP machines, accompanied by lightweight masks and accessories, allow patients to manage their sleep apnea treatment at home comfortably. This preference for homecare settings, driven by enhanced comfort and convenience, contributes to the growth of this segment.

To learn more about this report, Download Free Sample Report

Hospital and sleep lab segment is anticipated to experience substantial growth as sleep apnea devices play a crucial role in these settings for diagnosing, monitoring, managing, treating, and supporting patients with sleep-related breathing disorders. In addition, in critical care settings like ICUs, hospitals utilize sleep apnea devices such as Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) to aid patients with compromised respiratory functions, thereby driving segment growth.

Regional Insights

North America dominated the sleep apnea devices market with the largest revenue share of 47.6% in 2025. Changing lifestyles, growing disposable income, presence of renowned players, growing obese population, rising prevalence of respiratory diseases, growing awareness about OSA, and favorable government initiatives are some of the key factors driving the growth. Some of the key participants present in North America are Philips Respironics; Somnetics International Inc.; and ResMed. These companies have a strong business presence and have well-established supply & distribution channels across North America.

To learn more about this report, Download Free Sample Report

U.S. Sleep Apnea Devices Market Trends

The U.S. held the largest share of the North America sleep apnea devices market in 2025, driven by the high prevalence and diagnosis rates of obstructive sleep apnea, the widespread availability of sleep testing and specialized care, and the established adoption of treatment devices. In addition, favorable reimbursement coverage, growing awareness of the health risks associated with untreated sleep apnea, and the presence of major device manufacturers are contributing to the market's growth. 

Asia Pacific Sleep Apnea Devices Market Trends

Asia Pacific segment is anticipated to grow at the fastest rate of 8.0% over the forecast period owing to the growing geriatric population and rising prevalence of lifestyle diseases such as cardiovascular diseases, cancer, hypertension, diabetes, and chronic respiratory diseases. As per the OECD iLibrary article on Asia/Pacific 2020, approximately 227 million individuals are diagnosed with type 2 diabetes in the Asia Pacific. The growing prevalence of chronic conditions is expected to contribute to the surge in OSA and drive the adoption of sleep apnea devices in countries in the Asia Pacific.

Key Companies & Market Share Insights

The competitive sleep apnea devices market is characterized by a few notable players, including ResMed, Philips Respironics (a division of Philips), Fisher & Paykel Healthcare, among others. These manufacturers are actively pursuing strategic initiatives such as mergers and acquisitions to strengthen their market positions. For instance, in July 2023, ResMed acquired Somnoware, a U.S. leader in sleep and respiratory care Home Care software.

Key Sleep Apnea Devices Companies

The following key companies have been profiled for this study on the sleep apnea devices market.

• ResMed

• Respironics (a subsidiary of Koninklijke Philips N.V.)

• Fisher & Paykel Healthcare Limited

• Curative Medical, Inc.

• React Health (Respiratory Product Line from Invacare Corporation)

• Somnetics International, Inc.

• BMC Medical Co., Ltd.

• Natus Medical Incorporated

• SOMNOmedics GmbH

• Compumedics

• Itamar Medical Ltd.

• Nihon Kohden Corporation

Recent Developments

• In November 2023, Vivos Therapeutics obtained FDA 510(k) Clearance for its CARE (Complete Airway Repositioning and/or Expansion) oral devices tailored for adults with severe obstructive sleep apnea (OSA). This clearance covers the company's prominent DNA, mRNA, and mmRNA oral appliances.

• In October 2023, ResMed and Bittium Biosignals Ltd, a Bittium Corporation subsidiary, entered an agreement where ResMed becomes a distributor of Bittium Respiro, an advanced Home Sleep Apnea Test and Analysis Solution. The comprehensive solution includes the Bittium Respiro measuring device, its accessories, and the Bittium Respiro Analyst software analysis tool and service platform. The non-exclusive agreement covers Norway, the United Kingdom (UK), Switzerland, the Republic of Ireland, Finland, and Sweden

Global Sleep Apnea Devices Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the sleep apnea devices market report based on product type end use, and region.

To learn more about this report, Download Free Sample Report

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Diagnostic Devices

    • Actigraphs

    • Polysomnography (PSG) device

    • Respiratory Polygraphs

    • Pulse Oximeters

  • Therapeutic Devices

    • Positive Airway Pressure (PAP) Devices

      • CPAP

      • APAP

      • Bi-PAP

    • Oral Devices

    • Nasal Devices

    • Chin Straps

  • Sleep Apnea Masks

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals and Sleep Labs

  • Home Care

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Singapore

    • Thailand

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • U.A.E.

    • Kuwait

Research Methodology

The sleep apnea devices market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each sleep apnea devices segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations